These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12921253)

  • 21. Continuous infusion of ceftazidime in critically ill patients undergoing continuous venovenous haemodiafiltration: pharmacokinetic evaluation and dose recommendation.
    Mariat C; Venet C; Jehl F; Mwewa S; Lazarevic V; Diconne E; Fonsale N; Carricajo A; Guyomarc'h S; Vermesch R; Aubert G; Bidault R; Bertrand JC; Zeni F
    Crit Care; 2006 Feb; 10(1):R26. PubMed ID: 16507147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single dose pharmacokinetics of linezolid in infants and children.
    Kearns GL; Abdel-Rahman SM; Blumer JL; Reed MD; James LP; Jacobs RF; Bradley JA; Welshman IR; Jungbluth GL; Stalker DJ;
    Pediatr Infect Dis J; 2000 Dec; 19(12):1178-84. PubMed ID: 11144380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population pharmacokinetics of linezolid in critically ill patients on renal replacement therapy: comparison of equal doses in continuous venovenous haemofiltration and continuous venovenous haemodiafiltration.
    Roger C; Muller L; Wallis SC; Louart B; Saissi G; Lipman J; Lefrant JY; Roberts JA
    J Antimicrob Chemother; 2016 Feb; 71(2):464-70. PubMed ID: 26538503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and pharmacodynamics of once-daily arbekacin during continuous venovenous hemodiafiltration in critically ill patients.
    Ikawa K; Morikawa N; Suyama H; Ikeda K; Yamanoue T
    J Infect Chemother; 2009 Dec; 15(6):420-3. PubMed ID: 20012736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and tolerance of single- and multiple-dose oral or intravenous linezolid, an oxazolidinone antibiotic, in healthy volunteers.
    Stalker DJ; Jungbluth GL; Hopkins NK; Batts DH
    J Antimicrob Chemother; 2003 May; 51(5):1239-46. PubMed ID: 12668582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Target site pharmacokinetics of linezolid after single and multiple doses in diabetic patients with soft tissue infection.
    Eslam RB; Burian A; Vila G; Sauermann R; Hammer A; Frenzel D; Minichmayr IK; Kloft C; Matzneller P; Oesterreicher Z; Zeitlinger M
    J Clin Pharmacol; 2014 Sep; 54(9):1058-62. PubMed ID: 24677034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between serum linezolid concentration and the development of thrombocytopenia.
    Hiraki Y; Tsuji Y; Hiraike M; Misumi N; Matsumoto K; Morita K; Kamimura H; Karube Y
    Scand J Infect Dis; 2012 Jan; 44(1):60-4. PubMed ID: 21899392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of ontogeny on linezolid disposition in neonates and infants.
    Kearns GL; Jungbluth GL; Abdel-Rahman SM; Hopkins NK; Welshman IR; Grzebyk RP; Bruss JB; Van Den Anker JN;
    Clin Pharmacol Ther; 2003 Nov; 74(5):413-22. PubMed ID: 14586382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of repeated dosing of linezolid in a hemodialysis patient with chronic renal failure.
    Tsuji Y; Hiraki Y; Mizoguchi A; Hayashi W; Kamohara R; Kamimura H; Karube Y
    J Infect Chemother; 2008 Apr; 14(2):156-60. PubMed ID: 18622681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma and cerebrospinal fluid concentrations of linezolid in neurosurgical critically ill patients with proven or suspected central nervous system infections.
    Luque S; Grau S; Alvarez-Lerma F; Ferrández O; Campillo N; Horcajada JP; Basas M; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2014 Nov; 44(5):409-15. PubMed ID: 25216547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single- and multiple-dose pharmacokinetics of linezolid and co-amoxiclav in healthy human volunteers.
    Burkhardt O; Borner K; von der Höh N; Köppe P; Pletz MW; Nord CE; Lode H
    J Antimicrob Chemother; 2002 Nov; 50(5):707-12. PubMed ID: 12407127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linezolid pharmacokinetics in adult patients with cystic fibrosis.
    Bosso JA; Flume PA; Gray SL
    Antimicrob Agents Chemother; 2004 Jan; 48(1):281-4. PubMed ID: 14693551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum and cerebrospinal fluid concentrations of linezolid in neurosurgical patients.
    Myrianthefs P; Markantonis SL; Vlachos K; Anagnostaki M; Boutzouka E; Panidis D; Baltopoulos G
    Antimicrob Agents Chemother; 2006 Dec; 50(12):3971-6. PubMed ID: 16982782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of continuous venovenous hemofiltration and continuous venovenous hemodiafiltration on the disposition of doripenem.
    Cirillo I; Vaccaro N; Balis D; Redman R; Matzke GR
    Antimicrob Agents Chemother; 2011 Mar; 55(3):1187-93. PubMed ID: 21199922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Linezolid pharmacokinetic/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion.
    Adembri C; Fallani S; Cassetta MI; Arrigucci S; Ottaviano A; Pecile P; Mazzei T; De Gaudio R; Novelli A
    Int J Antimicrob Agents; 2008 Feb; 31(2):122-9. PubMed ID: 18055183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Weight-adjusted versus fixed dose of linezolid for Chinese healthy volunteers of higher and lower body weight: a Phase I pharmacokinetic and pharmacodynamic study.
    Cai Y; Chai D; Falagas ME; Karageorgopoulos DE; Wang R; Bai N; Liang B
    Expert Opin Investig Drugs; 2013 Mar; 22(3):309-15. PubMed ID: 23360474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of linezolid clearance on the induction of thrombocytopenia and reduction of hemoglobin.
    Hiraki Y; Tsuji Y; Matsumoto K; Morita K; Kamimura H; Karube Y
    Am J Med Sci; 2011 Dec; 342(6):456-60. PubMed ID: 21681075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator-associated pneumonia.
    Boselli E; Breilh D; Rimmelé T; Djabarouti S; Toutain J; Chassard D; Saux MC; Allaouchiche B
    Crit Care Med; 2005 Jul; 33(7):1529-33. PubMed ID: 16003058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Linezolid pharmacokinetics in pediatric patients: an overview.
    Jungbluth GL; Welshman IR; Hopkins NK
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S153-7. PubMed ID: 14520140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of unbound linezolid in plasma and tissue interstitium of critically ill patients after multiple dosing using microdialysis.
    Buerger C; Plock N; Dehghanyar P; Joukhadar C; Kloft C
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2455-63. PubMed ID: 16801426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.